Patents by Inventor Roger Victor Bonnert

Roger Victor Bonnert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS
    Publication number: 20080300244
    Abstract: The present invention provides compounds of formula wherein R1, Y1, X1, Z1, X2, Y2, A, n and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 13, 2007
    Publication date: December 4, 2008
    Applicant: AstraZeneca AB
    Inventors: Roger Victor BONNERT, Thomas McInally, Tobias Mochel, Stephen Thom
  • Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
    Publication number: 20080293775
    Abstract: The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Application
    Filed: December 12, 2006
    Publication date: November 27, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Roger Victor Bonnert, Andrew Cook, Timothy Jon Luker, Rukhsana Tasneem Mohammed, Stephen Thom
  • Chemical Compounds 636
    Publication number: 20080207650
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 28, 2008
    Inventors: Roger Victor Bonnert, Hitesh Jayantilal Sanganee
  • 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders
    Publication number: 20080027092
    Abstract: The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: November 24, 2004
    Publication date: January 31, 2008
    Inventors: Roger Victor Bonnert, Rukhsana Tasneem Mohammed, Simon Teague
  • Novel thiazolo (4,5-D) pyrimidine compounds
    Publication number: 20040224961
    Abstract: The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof; processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: June 9, 2004
    Publication date: November 11, 2004
    Applicant: AstraZeneca UK Limited, a British corporation
    Inventors: Paul Andrew Willis, Roger Victor Bonnert, Simon Fraser Hunt, Iain Alistair Stewart Walters
  • Thiazolo(4,5-d)pyrimidine compounds
    Patent number: 6790850
    Abstract: The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof; processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: September 14, 2004
    Assignee: AstraZeneca UK Limited
    Inventors: Paul Andrew Willis, Roger Victor Bonnert, Simon Fraser Hunt, Iain Alistair Stewart Walters
  • Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
    Patent number: 6297232
    Abstract: The invention relates to triazolo[4,5-d]pyrimidin-3-yl derivatives which are useful in the treatment of platelet aggregation disorders.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: October 2, 2001
    Assignee: AstraZeneca AB
    Inventors: Roger Victor Bonnert, Anthony Howard Ingall, Brian Springthorpe, Paul Andrew Willis
  • Benzothiazolone derivatives
    Patent number: 6080869
    Abstract: A compound of formula I, including optical isomers thereof, whereinX represents --SO.sub.2 NH-- or --NHSO.sub.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: June 27, 2000
    Assignee: Astra Pharmaceuticals Limited
    Inventors: Roger Victor Bonnert, Roger Charles Brown
  • Benzothiazolone derivatives
    Patent number: 6008365
    Abstract: A compound of formula I, including optical isomers thereof, ##STR1## wherein X represents --SO.sub.2 NH-- or --NHSO.sub.2 --,p, q and r independently represent 2 or 3,Y represents thienyl optionally substituted by alkyl or halogen, or phenylthio- or phenyloptionally substituted by akyl or halogen, andeach R independently represents H or alkyl,and pharmaceutically acceptable salts, esters and amides thereof.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: December 28, 1999
    Assignee: Astra Pharmaceuticals Ltd.
    Inventors: Roger Victor Bonnert, Roger Charles Brown
  • Benzothiazolone derivatives
    Patent number: 5977384
    Abstract: A compound of formula I, including optical isomers thereof, ##STR1## wherein X represents --SO.sub.2 NH-- or --NHSO.sub.2 --,p, q and r independently represent 2 or 3;Y represents thienyl optionally substituted by alkyl or halogen, or phenylthio- or phenyl optionally substituted by alkyl or halogen, andeach R independently represents H or alkyl,and pharmaceutically acceptable salts, esters and amides thereof.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: November 2, 1999
    Assignee: Astra Pharmaceuticals Ltd.
    Inventors: Roger Victor Bonnert, Roger Charles Brown
  • Intermediates for making benzothiazolone derivatives
    Patent number: 5973167
    Abstract: A compound of formula I, including optical isomers thereof, ##STR1## wherein X represents --SO.sub.2 NH-- or --NHSO.sub.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: October 26, 1999
    Assignee: Astra Pharmaceuticals Ltd.
    Inventors: Roger Victor Bonnert, Roger Charles Brown
  • Benzothiazolone derivatives
    Patent number: 5846989
    Abstract: A compound of formula I, including optical isomers thereof, ##STR1## wherein X represents --SO.sub.2 NH-- or --NHSO.sub.2 --,p, q and r independently represent 2 or 3,Y represents thienyl optionally substituted by alkyl or halogen, or phenylthio- or phenyl optionally substituted by alkyl or halogen, andeach R independently represents H or alkyl,and pharmaceutically acceptable salts, esters and amides thereof.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: December 8, 1998
    Assignee: Astra Pharmaceuticals Limited
    Inventors: Roger Victor Bonnert, Roger Charles Brown, Peter Alan Cage, Francis Ince, Garry Pairaudeau